Medical Devices & Consumables
Global Adeno-Associated Virus (AAV) Particles Market Research Report 2025
- Sep 24, 25
- ID: 523070
- Pages: 107
- Figures: 103
- Views: 8
Report Scope
This report aims to provide a comprehensive presentation of the global market for Adeno-Associated Virus (AAV) Particles, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adeno-Associated Virus (AAV) Particles.
The Adeno-Associated Virus (AAV) Particles market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adeno-Associated Virus (AAV) Particles market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adeno-Associated Virus (AAV) Particles manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Lonza
Addgene
Takara
Charles River Laboratories
SIRION Biotech
Thermo Fisher Scientific
OriGene Technologies
Cell Biolabs
GenScript
VectorBuilder
GeneCopoeia
AMSBIO
Creative Biogene
BPS Bioscience
Oxford Biomedica
FUJIFILM Diosynth Biotechnologies
Aldevron
Segment by Type
Custom-made
Pre-made
Segment by Application
Medical Institutions
Research Institute
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Adeno-Associated Virus (AAV) Particles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Adeno-Associated Virus (AAV) Particles in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Adeno-Associated Virus (AAV) Particles, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adeno-Associated Virus (AAV) Particles.
The Adeno-Associated Virus (AAV) Particles market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adeno-Associated Virus (AAV) Particles market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adeno-Associated Virus (AAV) Particles manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Lonza
Addgene
Takara
Charles River Laboratories
SIRION Biotech
Thermo Fisher Scientific
OriGene Technologies
Cell Biolabs
GenScript
VectorBuilder
GeneCopoeia
AMSBIO
Creative Biogene
BPS Bioscience
Oxford Biomedica
FUJIFILM Diosynth Biotechnologies
Aldevron
Segment by Type
Custom-made
Pre-made
Segment by Application
Medical Institutions
Research Institute
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Adeno-Associated Virus (AAV) Particles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Adeno-Associated Virus (AAV) Particles in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Adeno-Associated Virus (AAV) Particles Market Overview
1.1 Product Definition
1.2 Adeno-Associated Virus (AAV) Particles by Type
1.2.1 Global Adeno-Associated Virus (AAV) Particles Market Value Comparison by Type (2024 VS 2031)
1.2.2 Custom-made
1.2.3 Pre-made
1.3 Adeno-Associated Virus (AAV) Particles by Application
1.3.1 Global Adeno-Associated Virus (AAV) Particles Market Value by Application (2024 VS 2031)
1.3.2 Medical Institutions
1.3.3 Research Institute
1.4 Global Adeno-Associated Virus (AAV) Particles Market Size Estimates and Forecasts
1.4.1 Global Adeno-Associated Virus (AAV) Particles Revenue 2020-2031
1.4.2 Global Adeno-Associated Virus (AAV) Particles Sales 2020-2031
1.4.3 Global Adeno-Associated Virus (AAV) Particles Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Adeno-Associated Virus (AAV) Particles Market Competition by Manufacturers
2.1 Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Manufacturers (2020-2025)
2.2 Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Adeno-Associated Virus (AAV) Particles Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Adeno-Associated Virus (AAV) Particles, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Adeno-Associated Virus (AAV) Particles, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Adeno-Associated Virus (AAV) Particles, Product Type & Application
2.7 Global Key Manufacturers of Adeno-Associated Virus (AAV) Particles, Date of Enter into This Industry
2.8 Global Adeno-Associated Virus (AAV) Particles Market Competitive Situation and Trends
2.8.1 Global Adeno-Associated Virus (AAV) Particles Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Adeno-Associated Virus (AAV) Particles Players Market Share by Revenue
2.8.3 Global Adeno-Associated Virus (AAV) Particles Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Adeno-Associated Virus (AAV) Particles Market Scenario by Region
3.1 Global Adeno-Associated Virus (AAV) Particles Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Adeno-Associated Virus (AAV) Particles Sales by Region: 2020-2031
3.2.1 Global Adeno-Associated Virus (AAV) Particles Sales by Region: 2020-2025
3.2.2 Global Adeno-Associated Virus (AAV) Particles Sales by Region: 2026-2031
3.3 Global Adeno-Associated Virus (AAV) Particles Revenue by Region: 2020-2031
3.3.1 Global Adeno-Associated Virus (AAV) Particles Revenue by Region: 2020-2025
3.3.2 Global Adeno-Associated Virus (AAV) Particles Revenue by Region: 2026-2031
3.4 North America Adeno-Associated Virus (AAV) Particles Market Facts & Figures by Country
3.4.1 North America Adeno-Associated Virus (AAV) Particles Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2031)
3.4.3 North America Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Adeno-Associated Virus (AAV) Particles Market Facts & Figures by Country
3.5.1 Europe Adeno-Associated Virus (AAV) Particles Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2031)
3.5.3 Europe Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Adeno-Associated Virus (AAV) Particles Market Facts & Figures by Region
3.6.1 Asia Pacific Adeno-Associated Virus (AAV) Particles Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Adeno-Associated Virus (AAV) Particles Sales by Region (2020-2031)
3.6.3 Asia Pacific Adeno-Associated Virus (AAV) Particles Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Adeno-Associated Virus (AAV) Particles Market Facts & Figures by Country
3.7.1 Latin America Adeno-Associated Virus (AAV) Particles Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2031)
3.7.3 Latin America Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Adeno-Associated Virus (AAV) Particles Market Facts & Figures by Country
3.8.1 Middle East and Africa Adeno-Associated Virus (AAV) Particles Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2031)
3.8.3 Middle East and Africa Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Adeno-Associated Virus (AAV) Particles Sales by Type (2020-2031)
4.1.1 Global Adeno-Associated Virus (AAV) Particles Sales by Type (2020-2025)
4.1.2 Global Adeno-Associated Virus (AAV) Particles Sales by Type (2026-2031)
4.1.3 Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Type (2020-2031)
4.2 Global Adeno-Associated Virus (AAV) Particles Revenue by Type (2020-2031)
4.2.1 Global Adeno-Associated Virus (AAV) Particles Revenue by Type (2020-2025)
4.2.2 Global Adeno-Associated Virus (AAV) Particles Revenue by Type (2026-2031)
4.2.3 Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Type (2020-2031)
4.3 Global Adeno-Associated Virus (AAV) Particles Price by Type (2020-2031)
5 Segment by Application
5.1 Global Adeno-Associated Virus (AAV) Particles Sales by Application (2020-2031)
5.1.1 Global Adeno-Associated Virus (AAV) Particles Sales by Application (2020-2025)
5.1.2 Global Adeno-Associated Virus (AAV) Particles Sales by Application (2026-2031)
5.1.3 Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Application (2020-2031)
5.2 Global Adeno-Associated Virus (AAV) Particles Revenue by Application (2020-2031)
5.2.1 Global Adeno-Associated Virus (AAV) Particles Revenue by Application (2020-2025)
5.2.2 Global Adeno-Associated Virus (AAV) Particles Revenue by Application (2026-2031)
5.2.3 Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Application (2020-2031)
5.3 Global Adeno-Associated Virus (AAV) Particles Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Lonza
6.1.1 Lonza Company Information
6.1.2 Lonza Description and Business Overview
6.1.3 Lonza Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Lonza Adeno-Associated Virus (AAV) Particles Product Portfolio
6.1.5 Lonza Recent Developments/Updates
6.2 Addgene
6.2.1 Addgene Company Information
6.2.2 Addgene Description and Business Overview
6.2.3 Addgene Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Addgene Adeno-Associated Virus (AAV) Particles Product Portfolio
6.2.5 Addgene Recent Developments/Updates
6.3 Takara
6.3.1 Takara Company Information
6.3.2 Takara Description and Business Overview
6.3.3 Takara Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Takara Adeno-Associated Virus (AAV) Particles Product Portfolio
6.3.5 Takara Recent Developments/Updates
6.4 Charles River Laboratories
6.4.1 Charles River Laboratories Company Information
6.4.2 Charles River Laboratories Description and Business Overview
6.4.3 Charles River Laboratories Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Charles River Laboratories Adeno-Associated Virus (AAV) Particles Product Portfolio
6.4.5 Charles River Laboratories Recent Developments/Updates
6.5 SIRION Biotech
6.5.1 SIRION Biotech Company Information
6.5.2 SIRION Biotech Description and Business Overview
6.5.3 SIRION Biotech Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.5.4 SIRION Biotech Adeno-Associated Virus (AAV) Particles Product Portfolio
6.5.5 SIRION Biotech Recent Developments/Updates
6.6 Thermo Fisher Scientific
6.6.1 Thermo Fisher Scientific Company Information
6.6.2 Thermo Fisher Scientific Description and Business Overview
6.6.3 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Particles Product Portfolio
6.6.5 Thermo Fisher Scientific Recent Developments/Updates
6.7 OriGene Technologies
6.7.1 OriGene Technologies Company Information
6.7.2 OriGene Technologies Description and Business Overview
6.7.3 OriGene Technologies Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.7.4 OriGene Technologies Adeno-Associated Virus (AAV) Particles Product Portfolio
6.7.5 OriGene Technologies Recent Developments/Updates
6.8 Cell Biolabs
6.8.1 Cell Biolabs Company Information
6.8.2 Cell Biolabs Description and Business Overview
6.8.3 Cell Biolabs Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cell Biolabs Adeno-Associated Virus (AAV) Particles Product Portfolio
6.8.5 Cell Biolabs Recent Developments/Updates
6.9 GenScript
6.9.1 GenScript Company Information
6.9.2 GenScript Description and Business Overview
6.9.3 GenScript Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GenScript Adeno-Associated Virus (AAV) Particles Product Portfolio
6.9.5 GenScript Recent Developments/Updates
6.10 VectorBuilder
6.10.1 VectorBuilder Company Information
6.10.2 VectorBuilder Description and Business Overview
6.10.3 VectorBuilder Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.10.4 VectorBuilder Adeno-Associated Virus (AAV) Particles Product Portfolio
6.10.5 VectorBuilder Recent Developments/Updates
6.11 GeneCopoeia
6.11.1 GeneCopoeia Company Information
6.11.2 GeneCopoeia Description and Business Overview
6.11.3 GeneCopoeia Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.11.4 GeneCopoeia Adeno-Associated Virus (AAV) Particles Product Portfolio
6.11.5 GeneCopoeia Recent Developments/Updates
6.12 AMSBIO
6.12.1 AMSBIO Company Information
6.12.2 AMSBIO Description and Business Overview
6.12.3 AMSBIO Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.12.4 AMSBIO Adeno-Associated Virus (AAV) Particles Product Portfolio
6.12.5 AMSBIO Recent Developments/Updates
6.13 Creative Biogene
6.13.1 Creative Biogene Company Information
6.13.2 Creative Biogene Description and Business Overview
6.13.3 Creative Biogene Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Creative Biogene Adeno-Associated Virus (AAV) Particles Product Portfolio
6.13.5 Creative Biogene Recent Developments/Updates
6.14 BPS Bioscience
6.14.1 BPS Bioscience Company Information
6.14.2 BPS Bioscience Description and Business Overview
6.14.3 BPS Bioscience Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.14.4 BPS Bioscience Adeno-Associated Virus (AAV) Particles Product Portfolio
6.14.5 BPS Bioscience Recent Developments/Updates
6.15 Oxford Biomedica
6.15.1 Oxford Biomedica Company Information
6.15.2 Oxford Biomedica Description and Business Overview
6.15.3 Oxford Biomedica Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Oxford Biomedica Adeno-Associated Virus (AAV) Particles Product Portfolio
6.15.5 Oxford Biomedica Recent Developments/Updates
6.16 FUJIFILM Diosynth Biotechnologies
6.16.1 FUJIFILM Diosynth Biotechnologies Company Information
6.16.2 FUJIFILM Diosynth Biotechnologies Description and Business Overview
6.16.3 FUJIFILM Diosynth Biotechnologies Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.16.4 FUJIFILM Diosynth Biotechnologies Adeno-Associated Virus (AAV) Particles Product Portfolio
6.16.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
6.17 Aldevron
6.17.1 Aldevron Company Information
6.17.2 Aldevron Description and Business Overview
6.17.3 Aldevron Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Aldevron Adeno-Associated Virus (AAV) Particles Product Portfolio
6.17.5 Aldevron Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Adeno-Associated Virus (AAV) Particles Industry Chain Analysis
7.2 Adeno-Associated Virus (AAV) Particles Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Adeno-Associated Virus (AAV) Particles Production Mode & Process Analysis
7.4 Adeno-Associated Virus (AAV) Particles Sales and Marketing
7.4.1 Adeno-Associated Virus (AAV) Particles Sales Channels
7.4.2 Adeno-Associated Virus (AAV) Particles Distributors
7.5 Adeno-Associated Virus (AAV) Particles Customer Analysis
8 Adeno-Associated Virus (AAV) Particles Market Dynamics
8.1 Adeno-Associated Virus (AAV) Particles Industry Trends
8.2 Adeno-Associated Virus (AAV) Particles Market Drivers
8.3 Adeno-Associated Virus (AAV) Particles Market Challenges
8.4 Adeno-Associated Virus (AAV) Particles Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Adeno-Associated Virus (AAV) Particles by Type
1.2.1 Global Adeno-Associated Virus (AAV) Particles Market Value Comparison by Type (2024 VS 2031)
1.2.2 Custom-made
1.2.3 Pre-made
1.3 Adeno-Associated Virus (AAV) Particles by Application
1.3.1 Global Adeno-Associated Virus (AAV) Particles Market Value by Application (2024 VS 2031)
1.3.2 Medical Institutions
1.3.3 Research Institute
1.4 Global Adeno-Associated Virus (AAV) Particles Market Size Estimates and Forecasts
1.4.1 Global Adeno-Associated Virus (AAV) Particles Revenue 2020-2031
1.4.2 Global Adeno-Associated Virus (AAV) Particles Sales 2020-2031
1.4.3 Global Adeno-Associated Virus (AAV) Particles Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Adeno-Associated Virus (AAV) Particles Market Competition by Manufacturers
2.1 Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Manufacturers (2020-2025)
2.2 Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Adeno-Associated Virus (AAV) Particles Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Adeno-Associated Virus (AAV) Particles, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Adeno-Associated Virus (AAV) Particles, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Adeno-Associated Virus (AAV) Particles, Product Type & Application
2.7 Global Key Manufacturers of Adeno-Associated Virus (AAV) Particles, Date of Enter into This Industry
2.8 Global Adeno-Associated Virus (AAV) Particles Market Competitive Situation and Trends
2.8.1 Global Adeno-Associated Virus (AAV) Particles Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Adeno-Associated Virus (AAV) Particles Players Market Share by Revenue
2.8.3 Global Adeno-Associated Virus (AAV) Particles Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Adeno-Associated Virus (AAV) Particles Market Scenario by Region
3.1 Global Adeno-Associated Virus (AAV) Particles Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Adeno-Associated Virus (AAV) Particles Sales by Region: 2020-2031
3.2.1 Global Adeno-Associated Virus (AAV) Particles Sales by Region: 2020-2025
3.2.2 Global Adeno-Associated Virus (AAV) Particles Sales by Region: 2026-2031
3.3 Global Adeno-Associated Virus (AAV) Particles Revenue by Region: 2020-2031
3.3.1 Global Adeno-Associated Virus (AAV) Particles Revenue by Region: 2020-2025
3.3.2 Global Adeno-Associated Virus (AAV) Particles Revenue by Region: 2026-2031
3.4 North America Adeno-Associated Virus (AAV) Particles Market Facts & Figures by Country
3.4.1 North America Adeno-Associated Virus (AAV) Particles Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2031)
3.4.3 North America Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Adeno-Associated Virus (AAV) Particles Market Facts & Figures by Country
3.5.1 Europe Adeno-Associated Virus (AAV) Particles Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2031)
3.5.3 Europe Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Adeno-Associated Virus (AAV) Particles Market Facts & Figures by Region
3.6.1 Asia Pacific Adeno-Associated Virus (AAV) Particles Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Adeno-Associated Virus (AAV) Particles Sales by Region (2020-2031)
3.6.3 Asia Pacific Adeno-Associated Virus (AAV) Particles Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Adeno-Associated Virus (AAV) Particles Market Facts & Figures by Country
3.7.1 Latin America Adeno-Associated Virus (AAV) Particles Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2031)
3.7.3 Latin America Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Adeno-Associated Virus (AAV) Particles Market Facts & Figures by Country
3.8.1 Middle East and Africa Adeno-Associated Virus (AAV) Particles Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2031)
3.8.3 Middle East and Africa Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Adeno-Associated Virus (AAV) Particles Sales by Type (2020-2031)
4.1.1 Global Adeno-Associated Virus (AAV) Particles Sales by Type (2020-2025)
4.1.2 Global Adeno-Associated Virus (AAV) Particles Sales by Type (2026-2031)
4.1.3 Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Type (2020-2031)
4.2 Global Adeno-Associated Virus (AAV) Particles Revenue by Type (2020-2031)
4.2.1 Global Adeno-Associated Virus (AAV) Particles Revenue by Type (2020-2025)
4.2.2 Global Adeno-Associated Virus (AAV) Particles Revenue by Type (2026-2031)
4.2.3 Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Type (2020-2031)
4.3 Global Adeno-Associated Virus (AAV) Particles Price by Type (2020-2031)
5 Segment by Application
5.1 Global Adeno-Associated Virus (AAV) Particles Sales by Application (2020-2031)
5.1.1 Global Adeno-Associated Virus (AAV) Particles Sales by Application (2020-2025)
5.1.2 Global Adeno-Associated Virus (AAV) Particles Sales by Application (2026-2031)
5.1.3 Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Application (2020-2031)
5.2 Global Adeno-Associated Virus (AAV) Particles Revenue by Application (2020-2031)
5.2.1 Global Adeno-Associated Virus (AAV) Particles Revenue by Application (2020-2025)
5.2.2 Global Adeno-Associated Virus (AAV) Particles Revenue by Application (2026-2031)
5.2.3 Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Application (2020-2031)
5.3 Global Adeno-Associated Virus (AAV) Particles Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Lonza
6.1.1 Lonza Company Information
6.1.2 Lonza Description and Business Overview
6.1.3 Lonza Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Lonza Adeno-Associated Virus (AAV) Particles Product Portfolio
6.1.5 Lonza Recent Developments/Updates
6.2 Addgene
6.2.1 Addgene Company Information
6.2.2 Addgene Description and Business Overview
6.2.3 Addgene Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Addgene Adeno-Associated Virus (AAV) Particles Product Portfolio
6.2.5 Addgene Recent Developments/Updates
6.3 Takara
6.3.1 Takara Company Information
6.3.2 Takara Description and Business Overview
6.3.3 Takara Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Takara Adeno-Associated Virus (AAV) Particles Product Portfolio
6.3.5 Takara Recent Developments/Updates
6.4 Charles River Laboratories
6.4.1 Charles River Laboratories Company Information
6.4.2 Charles River Laboratories Description and Business Overview
6.4.3 Charles River Laboratories Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Charles River Laboratories Adeno-Associated Virus (AAV) Particles Product Portfolio
6.4.5 Charles River Laboratories Recent Developments/Updates
6.5 SIRION Biotech
6.5.1 SIRION Biotech Company Information
6.5.2 SIRION Biotech Description and Business Overview
6.5.3 SIRION Biotech Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.5.4 SIRION Biotech Adeno-Associated Virus (AAV) Particles Product Portfolio
6.5.5 SIRION Biotech Recent Developments/Updates
6.6 Thermo Fisher Scientific
6.6.1 Thermo Fisher Scientific Company Information
6.6.2 Thermo Fisher Scientific Description and Business Overview
6.6.3 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Thermo Fisher Scientific Adeno-Associated Virus (AAV) Particles Product Portfolio
6.6.5 Thermo Fisher Scientific Recent Developments/Updates
6.7 OriGene Technologies
6.7.1 OriGene Technologies Company Information
6.7.2 OriGene Technologies Description and Business Overview
6.7.3 OriGene Technologies Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.7.4 OriGene Technologies Adeno-Associated Virus (AAV) Particles Product Portfolio
6.7.5 OriGene Technologies Recent Developments/Updates
6.8 Cell Biolabs
6.8.1 Cell Biolabs Company Information
6.8.2 Cell Biolabs Description and Business Overview
6.8.3 Cell Biolabs Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cell Biolabs Adeno-Associated Virus (AAV) Particles Product Portfolio
6.8.5 Cell Biolabs Recent Developments/Updates
6.9 GenScript
6.9.1 GenScript Company Information
6.9.2 GenScript Description and Business Overview
6.9.3 GenScript Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GenScript Adeno-Associated Virus (AAV) Particles Product Portfolio
6.9.5 GenScript Recent Developments/Updates
6.10 VectorBuilder
6.10.1 VectorBuilder Company Information
6.10.2 VectorBuilder Description and Business Overview
6.10.3 VectorBuilder Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.10.4 VectorBuilder Adeno-Associated Virus (AAV) Particles Product Portfolio
6.10.5 VectorBuilder Recent Developments/Updates
6.11 GeneCopoeia
6.11.1 GeneCopoeia Company Information
6.11.2 GeneCopoeia Description and Business Overview
6.11.3 GeneCopoeia Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.11.4 GeneCopoeia Adeno-Associated Virus (AAV) Particles Product Portfolio
6.11.5 GeneCopoeia Recent Developments/Updates
6.12 AMSBIO
6.12.1 AMSBIO Company Information
6.12.2 AMSBIO Description and Business Overview
6.12.3 AMSBIO Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.12.4 AMSBIO Adeno-Associated Virus (AAV) Particles Product Portfolio
6.12.5 AMSBIO Recent Developments/Updates
6.13 Creative Biogene
6.13.1 Creative Biogene Company Information
6.13.2 Creative Biogene Description and Business Overview
6.13.3 Creative Biogene Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Creative Biogene Adeno-Associated Virus (AAV) Particles Product Portfolio
6.13.5 Creative Biogene Recent Developments/Updates
6.14 BPS Bioscience
6.14.1 BPS Bioscience Company Information
6.14.2 BPS Bioscience Description and Business Overview
6.14.3 BPS Bioscience Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.14.4 BPS Bioscience Adeno-Associated Virus (AAV) Particles Product Portfolio
6.14.5 BPS Bioscience Recent Developments/Updates
6.15 Oxford Biomedica
6.15.1 Oxford Biomedica Company Information
6.15.2 Oxford Biomedica Description and Business Overview
6.15.3 Oxford Biomedica Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Oxford Biomedica Adeno-Associated Virus (AAV) Particles Product Portfolio
6.15.5 Oxford Biomedica Recent Developments/Updates
6.16 FUJIFILM Diosynth Biotechnologies
6.16.1 FUJIFILM Diosynth Biotechnologies Company Information
6.16.2 FUJIFILM Diosynth Biotechnologies Description and Business Overview
6.16.3 FUJIFILM Diosynth Biotechnologies Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.16.4 FUJIFILM Diosynth Biotechnologies Adeno-Associated Virus (AAV) Particles Product Portfolio
6.16.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
6.17 Aldevron
6.17.1 Aldevron Company Information
6.17.2 Aldevron Description and Business Overview
6.17.3 Aldevron Adeno-Associated Virus (AAV) Particles Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Aldevron Adeno-Associated Virus (AAV) Particles Product Portfolio
6.17.5 Aldevron Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Adeno-Associated Virus (AAV) Particles Industry Chain Analysis
7.2 Adeno-Associated Virus (AAV) Particles Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Adeno-Associated Virus (AAV) Particles Production Mode & Process Analysis
7.4 Adeno-Associated Virus (AAV) Particles Sales and Marketing
7.4.1 Adeno-Associated Virus (AAV) Particles Sales Channels
7.4.2 Adeno-Associated Virus (AAV) Particles Distributors
7.5 Adeno-Associated Virus (AAV) Particles Customer Analysis
8 Adeno-Associated Virus (AAV) Particles Market Dynamics
8.1 Adeno-Associated Virus (AAV) Particles Industry Trends
8.2 Adeno-Associated Virus (AAV) Particles Market Drivers
8.3 Adeno-Associated Virus (AAV) Particles Market Challenges
8.4 Adeno-Associated Virus (AAV) Particles Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Adeno-Associated Virus (AAV) Particles Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Adeno-Associated Virus (AAV) Particles Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Adeno-Associated Virus (AAV) Particles Market Competitive Situation by Manufacturers in 2024
Table 4. Global Adeno-Associated Virus (AAV) Particles Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Adeno-Associated Virus (AAV) Particles Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Adeno-Associated Virus (AAV) Particles Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Adeno-Associated Virus (AAV) Particles Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Adeno-Associated Virus (AAV) Particles, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Adeno-Associated Virus (AAV) Particles, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Adeno-Associated Virus (AAV) Particles, Product Type & Application
Table 12. Global Key Manufacturers of Adeno-Associated Virus (AAV) Particles, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adeno-Associated Virus (AAV) Particles by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus (AAV) Particles as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Adeno-Associated Virus (AAV) Particles Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Adeno-Associated Virus (AAV) Particles Sales by Region (2020-2025) & (K Units)
Table 18. Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Region (2020-2025)
Table 19. Global Adeno-Associated Virus (AAV) Particles Sales by Region (2026-2031) & (K Units)
Table 20. Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Region (2026-2031)
Table 21. Global Adeno-Associated Virus (AAV) Particles Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Region (2020-2025)
Table 23. Global Adeno-Associated Virus (AAV) Particles Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Region (2026-2031)
Table 25. North America Adeno-Associated Virus (AAV) Particles Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2025) & (K Units)
Table 27. North America Adeno-Associated Virus (AAV) Particles Sales by Country (2026-2031) & (K Units)
Table 28. North America Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Adeno-Associated Virus (AAV) Particles Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Adeno-Associated Virus (AAV) Particles Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2025) & (K Units)
Table 32. Europe Adeno-Associated Virus (AAV) Particles Sales by Country (2026-2031) & (K Units)
Table 33. Europe Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Adeno-Associated Virus (AAV) Particles Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Adeno-Associated Virus (AAV) Particles Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Adeno-Associated Virus (AAV) Particles Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Adeno-Associated Virus (AAV) Particles Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Adeno-Associated Virus (AAV) Particles Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Adeno-Associated Virus (AAV) Particles Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Adeno-Associated Virus (AAV) Particles Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Adeno-Associated Virus (AAV) Particles Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Adeno-Associated Virus (AAV) Particles Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Adeno-Associated Virus (AAV) Particles Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Adeno-Associated Virus (AAV) Particles Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Adeno-Associated Virus (AAV) Particles Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Adeno-Associated Virus (AAV) Particles Sales (K Units) by Type (2020-2025)
Table 51. Global Adeno-Associated Virus (AAV) Particles Sales (K Units) by Type (2026-2031)
Table 52. Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Type (2020-2025)
Table 53. Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Type (2026-2031)
Table 54. Global Adeno-Associated Virus (AAV) Particles Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Adeno-Associated Virus (AAV) Particles Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Type (2020-2025)
Table 57. Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Type (2026-2031)
Table 58. Global Adeno-Associated Virus (AAV) Particles Price (US$/Unit) by Type (2020-2025)
Table 59. Global Adeno-Associated Virus (AAV) Particles Price (US$/Unit) by Type (2026-2031)
Table 60. Global Adeno-Associated Virus (AAV) Particles Sales (K Units) by Application (2020-2025)
Table 61. Global Adeno-Associated Virus (AAV) Particles Sales (K Units) by Application (2026-2031)
Table 62. Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Application (2020-2025)
Table 63. Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Application (2026-2031)
Table 64. Global Adeno-Associated Virus (AAV) Particles Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Adeno-Associated Virus (AAV) Particles Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Application (2020-2025)
Table 67. Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Application (2026-2031)
Table 68. Global Adeno-Associated Virus (AAV) Particles Price (US$/Unit) by Application (2020-2025)
Table 69. Global Adeno-Associated Virus (AAV) Particles Price (US$/Unit) by Application (2026-2031)
Table 70. Lonza Company Information
Table 71. Lonza Description and Business Overview
Table 72. Lonza Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Lonza Adeno-Associated Virus (AAV) Particles Product
Table 74. Lonza Recent Developments/Updates
Table 75. Addgene Company Information
Table 76. Addgene Description and Business Overview
Table 77. Addgene Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Addgene Adeno-Associated Virus (AAV) Particles Product
Table 79. Addgene Recent Developments/Updates
Table 80. Takara Company Information
Table 81. Takara Description and Business Overview
Table 82. Takara Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Takara Adeno-Associated Virus (AAV) Particles Product
Table 84. Takara Recent Developments/Updates
Table 85. Charles River Laboratories Company Information
Table 86. Charles River Laboratories Description and Business Overview
Table 87. Charles River Laboratories Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Charles River Laboratories Adeno-Associated Virus (AAV) Particles Product
Table 89. Charles River Laboratories Recent Developments/Updates
Table 90. SIRION Biotech Company Information
Table 91. SIRION Biotech Description and Business Overview
Table 92. SIRION Biotech Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. SIRION Biotech Adeno-Associated Virus (AAV) Particles Product
Table 94. SIRION Biotech Recent Developments/Updates
Table 95. Thermo Fisher Scientific Company Information
Table 96. Thermo Fisher Scientific Description and Business Overview
Table 97. Thermo Fisher Scientific Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Thermo Fisher Scientific Adeno-Associated Virus (AAV) Particles Product
Table 99. Thermo Fisher Scientific Recent Developments/Updates
Table 100. OriGene Technologies Company Information
Table 101. OriGene Technologies Description and Business Overview
Table 102. OriGene Technologies Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. OriGene Technologies Adeno-Associated Virus (AAV) Particles Product
Table 104. OriGene Technologies Recent Developments/Updates
Table 105. Cell Biolabs Company Information
Table 106. Cell Biolabs Description and Business Overview
Table 107. Cell Biolabs Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Cell Biolabs Adeno-Associated Virus (AAV) Particles Product
Table 109. Cell Biolabs Recent Developments/Updates
Table 110. GenScript Company Information
Table 111. GenScript Description and Business Overview
Table 112. GenScript Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. GenScript Adeno-Associated Virus (AAV) Particles Product
Table 114. GenScript Recent Developments/Updates
Table 115. VectorBuilder Company Information
Table 116. VectorBuilder Description and Business Overview
Table 117. VectorBuilder Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. VectorBuilder Adeno-Associated Virus (AAV) Particles Product
Table 119. VectorBuilder Recent Developments/Updates
Table 120. GeneCopoeia Company Information
Table 121. GeneCopoeia Description and Business Overview
Table 122. GeneCopoeia Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. GeneCopoeia Adeno-Associated Virus (AAV) Particles Product
Table 124. GeneCopoeia Recent Developments/Updates
Table 125. AMSBIO Company Information
Table 126. AMSBIO Description and Business Overview
Table 127. AMSBIO Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. AMSBIO Adeno-Associated Virus (AAV) Particles Product
Table 129. AMSBIO Recent Developments/Updates
Table 130. Creative Biogene Company Information
Table 131. Creative Biogene Description and Business Overview
Table 132. Creative Biogene Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Creative Biogene Adeno-Associated Virus (AAV) Particles Product
Table 134. Creative Biogene Recent Developments/Updates
Table 135. BPS Bioscience Company Information
Table 136. BPS Bioscience Description and Business Overview
Table 137. BPS Bioscience Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. BPS Bioscience Adeno-Associated Virus (AAV) Particles Product
Table 139. BPS Bioscience Recent Developments/Updates
Table 140. Oxford Biomedica Company Information
Table 141. Oxford Biomedica Description and Business Overview
Table 142. Oxford Biomedica Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Oxford Biomedica Adeno-Associated Virus (AAV) Particles Product
Table 144. Oxford Biomedica Recent Developments/Updates
Table 145. FUJIFILM Diosynth Biotechnologies Company Information
Table 146. FUJIFILM Diosynth Biotechnologies Description and Business Overview
Table 147. FUJIFILM Diosynth Biotechnologies Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. FUJIFILM Diosynth Biotechnologies Adeno-Associated Virus (AAV) Particles Product
Table 149. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 150. Aldevron Company Information
Table 151. Aldevron Description and Business Overview
Table 152. Aldevron Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Aldevron Adeno-Associated Virus (AAV) Particles Product
Table 154. Aldevron Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Adeno-Associated Virus (AAV) Particles Distributors List
Table 158. Adeno-Associated Virus (AAV) Particles Customers List
Table 159. Adeno-Associated Virus (AAV) Particles Market Trends
Table 160. Adeno-Associated Virus (AAV) Particles Market Drivers
Table 161. Adeno-Associated Virus (AAV) Particles Market Challenges
Table 162. Adeno-Associated Virus (AAV) Particles Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Adeno-Associated Virus (AAV) Particles
Figure 2. Global Adeno-Associated Virus (AAV) Particles Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Adeno-Associated Virus (AAV) Particles Market Share by Type: 2024 & 2031
Figure 4. Custom-made Product Picture
Figure 5. Pre-made Product Picture
Figure 6. Global Adeno-Associated Virus (AAV) Particles Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Adeno-Associated Virus (AAV) Particles Market Share by Application: 2024 & 2031
Figure 8. Medical Institutions
Figure 9. Research Institute
Figure 10. Global Adeno-Associated Virus (AAV) Particles Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Adeno-Associated Virus (AAV) Particles Market Size (2020-2031) & (US$ Million)
Figure 12. Global Adeno-Associated Virus (AAV) Particles Sales (2020-2031) & (K Units)
Figure 13. Global Adeno-Associated Virus (AAV) Particles Average Price (US$/Unit) & (2020-2031)
Figure 14. Adeno-Associated Virus (AAV) Particles Report Years Considered
Figure 15. Adeno-Associated Virus (AAV) Particles Sales Share by Manufacturers in 2024
Figure 16. Global Adeno-Associated Virus (AAV) Particles Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Adeno-Associated Virus (AAV) Particles Players: Market Share by Revenue in Adeno-Associated Virus (AAV) Particles in 2024
Figure 18. Adeno-Associated Virus (AAV) Particles Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Adeno-Associated Virus (AAV) Particles Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Adeno-Associated Virus (AAV) Particles Sales Market Share by Country (2020-2031)
Figure 21. North America Adeno-Associated Virus (AAV) Particles Revenue Market Share by Country (2020-2031)
Figure 22. United States Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Adeno-Associated Virus (AAV) Particles Sales Market Share by Country (2020-2031)
Figure 25. Europe Adeno-Associated Virus (AAV) Particles Revenue Market Share by Country (2020-2031)
Figure 26. Germany Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Adeno-Associated Virus (AAV) Particles Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Adeno-Associated Virus (AAV) Particles Revenue Market Share by Region (2020-2031)
Figure 33. China Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Adeno-Associated Virus (AAV) Particles Sales Market Share by Country (2020-2031)
Figure 41. Latin America Adeno-Associated Virus (AAV) Particles Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Middle East and Africa Adeno-Associated Virus (AAV) Particles Sales Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Adeno-Associated Virus (AAV) Particles Revenue Market Share by Country (2020-2031)
Figure 47. Turkey Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. UAE Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Global Sales Market Share of Adeno-Associated Virus (AAV) Particles by Type (2020-2031)
Figure 51. Global Revenue Market Share of Adeno-Associated Virus (AAV) Particles by Type (2020-2031)
Figure 52. Global Adeno-Associated Virus (AAV) Particles Price (US$/Unit) by Type (2020-2031)
Figure 53. Global Sales Market Share of Adeno-Associated Virus (AAV) Particles by Application (2020-2031)
Figure 54. Global Revenue Market Share of Adeno-Associated Virus (AAV) Particles by Application (2020-2031)
Figure 55. Global Adeno-Associated Virus (AAV) Particles Price (US$/Unit) by Application (2020-2031)
Figure 56. Adeno-Associated Virus (AAV) Particles Value Chain
Figure 57. Channels of Distribution (Direct Vs Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Adeno-Associated Virus (AAV) Particles Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Adeno-Associated Virus (AAV) Particles Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Adeno-Associated Virus (AAV) Particles Market Competitive Situation by Manufacturers in 2024
Table 4. Global Adeno-Associated Virus (AAV) Particles Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Adeno-Associated Virus (AAV) Particles Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Adeno-Associated Virus (AAV) Particles Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Adeno-Associated Virus (AAV) Particles Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Adeno-Associated Virus (AAV) Particles, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Adeno-Associated Virus (AAV) Particles, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Adeno-Associated Virus (AAV) Particles, Product Type & Application
Table 12. Global Key Manufacturers of Adeno-Associated Virus (AAV) Particles, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adeno-Associated Virus (AAV) Particles by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus (AAV) Particles as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Adeno-Associated Virus (AAV) Particles Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Adeno-Associated Virus (AAV) Particles Sales by Region (2020-2025) & (K Units)
Table 18. Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Region (2020-2025)
Table 19. Global Adeno-Associated Virus (AAV) Particles Sales by Region (2026-2031) & (K Units)
Table 20. Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Region (2026-2031)
Table 21. Global Adeno-Associated Virus (AAV) Particles Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Region (2020-2025)
Table 23. Global Adeno-Associated Virus (AAV) Particles Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Region (2026-2031)
Table 25. North America Adeno-Associated Virus (AAV) Particles Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2025) & (K Units)
Table 27. North America Adeno-Associated Virus (AAV) Particles Sales by Country (2026-2031) & (K Units)
Table 28. North America Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Adeno-Associated Virus (AAV) Particles Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Adeno-Associated Virus (AAV) Particles Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2025) & (K Units)
Table 32. Europe Adeno-Associated Virus (AAV) Particles Sales by Country (2026-2031) & (K Units)
Table 33. Europe Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Adeno-Associated Virus (AAV) Particles Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Adeno-Associated Virus (AAV) Particles Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Adeno-Associated Virus (AAV) Particles Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Adeno-Associated Virus (AAV) Particles Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Adeno-Associated Virus (AAV) Particles Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Adeno-Associated Virus (AAV) Particles Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Adeno-Associated Virus (AAV) Particles Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Adeno-Associated Virus (AAV) Particles Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Adeno-Associated Virus (AAV) Particles Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Adeno-Associated Virus (AAV) Particles Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Adeno-Associated Virus (AAV) Particles Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Adeno-Associated Virus (AAV) Particles Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Adeno-Associated Virus (AAV) Particles Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Adeno-Associated Virus (AAV) Particles Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Adeno-Associated Virus (AAV) Particles Sales (K Units) by Type (2020-2025)
Table 51. Global Adeno-Associated Virus (AAV) Particles Sales (K Units) by Type (2026-2031)
Table 52. Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Type (2020-2025)
Table 53. Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Type (2026-2031)
Table 54. Global Adeno-Associated Virus (AAV) Particles Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Adeno-Associated Virus (AAV) Particles Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Type (2020-2025)
Table 57. Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Type (2026-2031)
Table 58. Global Adeno-Associated Virus (AAV) Particles Price (US$/Unit) by Type (2020-2025)
Table 59. Global Adeno-Associated Virus (AAV) Particles Price (US$/Unit) by Type (2026-2031)
Table 60. Global Adeno-Associated Virus (AAV) Particles Sales (K Units) by Application (2020-2025)
Table 61. Global Adeno-Associated Virus (AAV) Particles Sales (K Units) by Application (2026-2031)
Table 62. Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Application (2020-2025)
Table 63. Global Adeno-Associated Virus (AAV) Particles Sales Market Share by Application (2026-2031)
Table 64. Global Adeno-Associated Virus (AAV) Particles Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Adeno-Associated Virus (AAV) Particles Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Application (2020-2025)
Table 67. Global Adeno-Associated Virus (AAV) Particles Revenue Market Share by Application (2026-2031)
Table 68. Global Adeno-Associated Virus (AAV) Particles Price (US$/Unit) by Application (2020-2025)
Table 69. Global Adeno-Associated Virus (AAV) Particles Price (US$/Unit) by Application (2026-2031)
Table 70. Lonza Company Information
Table 71. Lonza Description and Business Overview
Table 72. Lonza Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Lonza Adeno-Associated Virus (AAV) Particles Product
Table 74. Lonza Recent Developments/Updates
Table 75. Addgene Company Information
Table 76. Addgene Description and Business Overview
Table 77. Addgene Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Addgene Adeno-Associated Virus (AAV) Particles Product
Table 79. Addgene Recent Developments/Updates
Table 80. Takara Company Information
Table 81. Takara Description and Business Overview
Table 82. Takara Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Takara Adeno-Associated Virus (AAV) Particles Product
Table 84. Takara Recent Developments/Updates
Table 85. Charles River Laboratories Company Information
Table 86. Charles River Laboratories Description and Business Overview
Table 87. Charles River Laboratories Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Charles River Laboratories Adeno-Associated Virus (AAV) Particles Product
Table 89. Charles River Laboratories Recent Developments/Updates
Table 90. SIRION Biotech Company Information
Table 91. SIRION Biotech Description and Business Overview
Table 92. SIRION Biotech Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. SIRION Biotech Adeno-Associated Virus (AAV) Particles Product
Table 94. SIRION Biotech Recent Developments/Updates
Table 95. Thermo Fisher Scientific Company Information
Table 96. Thermo Fisher Scientific Description and Business Overview
Table 97. Thermo Fisher Scientific Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Thermo Fisher Scientific Adeno-Associated Virus (AAV) Particles Product
Table 99. Thermo Fisher Scientific Recent Developments/Updates
Table 100. OriGene Technologies Company Information
Table 101. OriGene Technologies Description and Business Overview
Table 102. OriGene Technologies Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. OriGene Technologies Adeno-Associated Virus (AAV) Particles Product
Table 104. OriGene Technologies Recent Developments/Updates
Table 105. Cell Biolabs Company Information
Table 106. Cell Biolabs Description and Business Overview
Table 107. Cell Biolabs Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Cell Biolabs Adeno-Associated Virus (AAV) Particles Product
Table 109. Cell Biolabs Recent Developments/Updates
Table 110. GenScript Company Information
Table 111. GenScript Description and Business Overview
Table 112. GenScript Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. GenScript Adeno-Associated Virus (AAV) Particles Product
Table 114. GenScript Recent Developments/Updates
Table 115. VectorBuilder Company Information
Table 116. VectorBuilder Description and Business Overview
Table 117. VectorBuilder Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. VectorBuilder Adeno-Associated Virus (AAV) Particles Product
Table 119. VectorBuilder Recent Developments/Updates
Table 120. GeneCopoeia Company Information
Table 121. GeneCopoeia Description and Business Overview
Table 122. GeneCopoeia Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. GeneCopoeia Adeno-Associated Virus (AAV) Particles Product
Table 124. GeneCopoeia Recent Developments/Updates
Table 125. AMSBIO Company Information
Table 126. AMSBIO Description and Business Overview
Table 127. AMSBIO Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. AMSBIO Adeno-Associated Virus (AAV) Particles Product
Table 129. AMSBIO Recent Developments/Updates
Table 130. Creative Biogene Company Information
Table 131. Creative Biogene Description and Business Overview
Table 132. Creative Biogene Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Creative Biogene Adeno-Associated Virus (AAV) Particles Product
Table 134. Creative Biogene Recent Developments/Updates
Table 135. BPS Bioscience Company Information
Table 136. BPS Bioscience Description and Business Overview
Table 137. BPS Bioscience Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. BPS Bioscience Adeno-Associated Virus (AAV) Particles Product
Table 139. BPS Bioscience Recent Developments/Updates
Table 140. Oxford Biomedica Company Information
Table 141. Oxford Biomedica Description and Business Overview
Table 142. Oxford Biomedica Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Oxford Biomedica Adeno-Associated Virus (AAV) Particles Product
Table 144. Oxford Biomedica Recent Developments/Updates
Table 145. FUJIFILM Diosynth Biotechnologies Company Information
Table 146. FUJIFILM Diosynth Biotechnologies Description and Business Overview
Table 147. FUJIFILM Diosynth Biotechnologies Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. FUJIFILM Diosynth Biotechnologies Adeno-Associated Virus (AAV) Particles Product
Table 149. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 150. Aldevron Company Information
Table 151. Aldevron Description and Business Overview
Table 152. Aldevron Adeno-Associated Virus (AAV) Particles Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Aldevron Adeno-Associated Virus (AAV) Particles Product
Table 154. Aldevron Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Adeno-Associated Virus (AAV) Particles Distributors List
Table 158. Adeno-Associated Virus (AAV) Particles Customers List
Table 159. Adeno-Associated Virus (AAV) Particles Market Trends
Table 160. Adeno-Associated Virus (AAV) Particles Market Drivers
Table 161. Adeno-Associated Virus (AAV) Particles Market Challenges
Table 162. Adeno-Associated Virus (AAV) Particles Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Adeno-Associated Virus (AAV) Particles
Figure 2. Global Adeno-Associated Virus (AAV) Particles Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Adeno-Associated Virus (AAV) Particles Market Share by Type: 2024 & 2031
Figure 4. Custom-made Product Picture
Figure 5. Pre-made Product Picture
Figure 6. Global Adeno-Associated Virus (AAV) Particles Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Adeno-Associated Virus (AAV) Particles Market Share by Application: 2024 & 2031
Figure 8. Medical Institutions
Figure 9. Research Institute
Figure 10. Global Adeno-Associated Virus (AAV) Particles Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Adeno-Associated Virus (AAV) Particles Market Size (2020-2031) & (US$ Million)
Figure 12. Global Adeno-Associated Virus (AAV) Particles Sales (2020-2031) & (K Units)
Figure 13. Global Adeno-Associated Virus (AAV) Particles Average Price (US$/Unit) & (2020-2031)
Figure 14. Adeno-Associated Virus (AAV) Particles Report Years Considered
Figure 15. Adeno-Associated Virus (AAV) Particles Sales Share by Manufacturers in 2024
Figure 16. Global Adeno-Associated Virus (AAV) Particles Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Adeno-Associated Virus (AAV) Particles Players: Market Share by Revenue in Adeno-Associated Virus (AAV) Particles in 2024
Figure 18. Adeno-Associated Virus (AAV) Particles Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Adeno-Associated Virus (AAV) Particles Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Adeno-Associated Virus (AAV) Particles Sales Market Share by Country (2020-2031)
Figure 21. North America Adeno-Associated Virus (AAV) Particles Revenue Market Share by Country (2020-2031)
Figure 22. United States Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Adeno-Associated Virus (AAV) Particles Sales Market Share by Country (2020-2031)
Figure 25. Europe Adeno-Associated Virus (AAV) Particles Revenue Market Share by Country (2020-2031)
Figure 26. Germany Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Adeno-Associated Virus (AAV) Particles Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Adeno-Associated Virus (AAV) Particles Revenue Market Share by Region (2020-2031)
Figure 33. China Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Adeno-Associated Virus (AAV) Particles Sales Market Share by Country (2020-2031)
Figure 41. Latin America Adeno-Associated Virus (AAV) Particles Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Middle East and Africa Adeno-Associated Virus (AAV) Particles Sales Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Adeno-Associated Virus (AAV) Particles Revenue Market Share by Country (2020-2031)
Figure 47. Turkey Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. UAE Adeno-Associated Virus (AAV) Particles Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Global Sales Market Share of Adeno-Associated Virus (AAV) Particles by Type (2020-2031)
Figure 51. Global Revenue Market Share of Adeno-Associated Virus (AAV) Particles by Type (2020-2031)
Figure 52. Global Adeno-Associated Virus (AAV) Particles Price (US$/Unit) by Type (2020-2031)
Figure 53. Global Sales Market Share of Adeno-Associated Virus (AAV) Particles by Application (2020-2031)
Figure 54. Global Revenue Market Share of Adeno-Associated Virus (AAV) Particles by Application (2020-2031)
Figure 55. Global Adeno-Associated Virus (AAV) Particles Price (US$/Unit) by Application (2020-2031)
Figure 56. Adeno-Associated Virus (AAV) Particles Value Chain
Figure 57. Channels of Distribution (Direct Vs Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global LED Light Housing Market Research Report 2025
Sep 24, 25
Global Side Emitting LED Strip Light Market Research Report 2025
Sep 24, 25
Global Medium and Low Voltage Unshielded Cable Market Research Report 2025
Sep 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232